Home/Filings/4/0001127602-13-004641
4//SEC Filing

Pawlicki Raymond 4

Accession 0001127602-13-004641

CIK 0000875045other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 1:55 PM ET

Size

8.4 KB

Accession

0001127602-13-004641

Insider Transaction Report

Form 4
Period: 2013-02-06
Pawlicki Raymond
SVP, Chief Information Officer
Transactions
  • Sale

    Common Stock

    2013-02-06$165.55/sh10,000$1,655,5007,652.711 total
  • Exercise/Conversion

    Common Stock

    2013-02-06$49.65/sh+10,000$496,50017,652.711 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-02-0610,0007,855 total
    Exercise: $49.65Exp: 2019-02-24Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  • [F2]The stock options vest in four (4) equal annual installments commencing one year after the grant date of 02/24/09.

Issuer

BIOGEN IDEC INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001547904

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 1:55 PM ET
Size
8.4 KB